// App-Quantinova.ai

: Long‐term Safety and Efficacy of Nonacog Beta Pegol in Previously Treated Children with Haemophilia B, Treated for at Least 5 Years

Researchers

Presenter

  • M. Carcao

Principal Investigators

  • S. Kearney

  • M. Taki

  • D. Rubens

  • K. Pietzko

  • E. Santagostino

Medical Centers

  • Hospital for Sick Children, Division of Gastroenterology, Toronto, Canada

  • Children's Hospital and Clinics of Minnesota, Hemophilia Treatment Center, Minneapolis, United States

  • St Marianna University School of Medicine, Department of Pediatrics, Kawasaki, Japan

  • Novo NordiskA/S, Soborg, Denmark

  • Angelo Bianchi Bonomi Haemophilia andThrombosis Center. IRCCS Ca Granda Foundation,Maggiore Hospital, Milan, Italy

Locations

  • Canada

  • United States

  • Japan

  • Denmark

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved